Filippo Mazzi: IVIG as an Alternative Therapy for Acute Chest Syndrome in Patients with Sickle Cell Disease
Filippo Mazzi, Medical Doctor at Integrated University Hospital of Verona, Italy, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“Excited to share our latest publication in Haematologica.
What can we do when a life-saving treatment is not an option?
We report two challenging cases of acute chest syndrome in patients with sickle cell disease who could not receive blood transfusions for religious reasons. We explored the use of intravenous immunoglobulins (IVIG) as an alternative therapeutic approach, with encouraging clinical outcomes.
These cases highlight how innovative and flexible treatment strategies can help address complex clinical scenarios in sickle cell disease and drive innovation in patient care.
Grateful to all co-authors and collaborators for this work.”
Title: Intravenous immunoglobulins in the management of acute chest syndrome in two Jehovah’s Witnesses with sickle cell disease
Authors: Francesca Begali, Jacopo Ceolan, Silvia Vitale, Simone Villaboni, Matteo Merlo, Rachele Zamperini, Roberto Bertazzo, Soraia Ribeiro Luz, Filippo Mazzi, Lucia De Franceschi
Read the Full Article on Haematologica.

Stay updated on all scientific advances with Hemostasis Today.
-
Apr 26, 2026, 05:43Pablo Corral: The Interplay Between Lipoprotein(a) and Interleukin-6 in Determining Primary Cardiovascular Risk
-
Apr 26, 2026, 05:37Bishal Gyawali: A Practical Guide to Reading Clinical Trial Reports
-
Apr 26, 2026, 05:32Expert Care When It Matters Most – Johns Hopkins All Children’s Hospital
-
Apr 26, 2026, 05:20Honoring the 2025 Excellence in Patient Advocacy Award – The Max Foundation
-
Apr 26, 2026, 05:03Ursula Porage Dona: From Inspiring Knowledge to Hearing Firsthand Stories
-
Apr 26, 2026, 04:34ASH – ISTH Pediatric VTE Prophylaxis Guidelines in The ASCO Post
-
Apr 26, 2026, 03:27Gianpiero Gravante: Comparative Evaluation of Surgical Strategies for Grade III Hemorrhoidal Disease
-
Apr 25, 2026, 17:10Abdul Mannan: 10-Minute FVIII Inhibitor Screening Test
-
Apr 25, 2026, 16:55Connie Montgomery: Highlights from the Hemophilia Federation of America Symposium 2026